0001493152-23-006247 Sample Contracts
COMMON STOCK PURCHASE WARRANT SIGYN THERAPEUTICS INC.Common Stock Purchase Warrant • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Brio Capital Master Fund Ltd. or its assigns (the “Holder”‘) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 23,2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from SIGYN THERAPEUTICS INC. (the “Company”), up to 220,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Standard Contracts
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE APRIL 28, 2023Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of S1GYN THERAPEUTICS INC., a Delaware corporation (the “Company”), having its principal place of business at Historic Decatur Drive, Suite 140, San Diego, CA. 92106, designated as its Original Issue Discount Senior Secured Debenture due April 28, 2023 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE DUE SEPTEMBER 9, 2023Convertible Security Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued Senior Convertible Debentures of SIGYN THERAPEUTICS INC., a Delaware corporation (the “Company”), having its principal place of business at Historic Decatur Drive, Suite 140, San Diego, CA. 92106, designated as its Original Issue Discount Senior Secured Debenture due May 10,2023 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
Annex ILease Agreement • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus
This Lease Agreement (this “Lease”) is entered into between LVA5 SAN DIEGO LS, L.P., a Delaware limited partnership (“Landlord”), and SIGYN THERAPEUTICS, INC., a Delaware corporation (“Tenant”), effective as of the date set forth below Landlord’s signature (the “Effective Date”).
COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • February 28th, 2023 • Sigyn Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Alpha Capital Anstalt or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on January 29, 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Sigyn Therapeutics, Inc. (the “Company”), up to 80,209 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).